Company Overview of 5AM Venture Management LLC
5AM Ventures is a venture capital firm specializing in seed, early-stage, startup investments, and spinouts. The firm prefers to invest in life science companies with a focus on drug development, biotechnology, product discovery platforms, and medical technologies. In drug development, it focuses on companies discovering and developing drugs focused on specific therapeutic areas such as anti-infectives, diabetes, metabolic diseases, and oncology. Within medical technologies, the firm focuses on areas such as drug delivery, diagnostics, imaging agents, materials science, and medical devices. It prefers to be the lead investor and make equity investments. It seeks to take a board seat of the m...
2200 Sand Hill Road
Menlo Park, CA 94025
Founded in 2002
Key Executives for 5AM Venture Management LLC
Managing Partner and Founder
Co-Founder and Managing Partner
General Counsel and Chief Operating Officer
Compensation as of Fiscal Year 2015.
5AM Venture Management LLC Key Developments
5AM Venture Management LLC Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 03:15 PM
Oct 2 15
5AM Venture Management LLC Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 03:15 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Kush M. Parmar, Managing Partner.
5AM Venture Management LLC Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
5AM Venture Management LLC Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
5AM Venture Management LLC Announces Executive Appointments
Nov 11 14
5AM Venture Management LLC announced the addition of Brian F. Daniels, M.D. as a Venture Partner and Stephen J. Bonelli, C.P.A. as Chief Financial Officer. Dr. Daniels has extensive experience in clinical development, medical affairs and corporate strategy across a broad range of therapeutic areas. He most recently was Senior Vice President, Global Development and Medical Affairs for Bristol-Myers Squibb, and a member of the Senior Management Team, the company’s most senior leadership group. Steve Bonelli recently joined 5AM from Three Arch Partners, where he was CFO from 2005-2014. Prior to Three Arch, Steve had over 20 years of experience as a financial professional, including ten years as senior financial executive in the life sciences industry. He served as CFO of U-Systems.
Similar Private Companies By Industry
Recent Private Companies Transactions